Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABC.L Share News (ABC)

  • There is currently no data for ABC

ABC.L News

Abcam Acquires Live Cell Line And Lysates Portfolio From EdiGene
16 Jul 2019

Abcam Acquires Live Cell Line And Lysates Portfolio From EdiGene

(Alliance News) - Abcam PLC said Tuesday it has acquired the live cell line and lysates portfolio of EdiGene Inc, a company which uses genome editing ...

UK Earnings, Trading Statements Calendar - Next 7 Days
15 Jul 2019

UK Earnings, Trading Statements Calendar - Next 7 Days

Tuesday 16 July HaysTrading Statement ExperianQ1 ResultsBurberry

Thursday broker round-up
27 Jun 2019

Thursday broker round-up

(Sharecast News) - Rightmove: UBS downgrades to sell with a target price of 505p.

Monday broker round-up
25 Mar 2019

Monday broker round-up

(Sharecast News) - Wood Group: Jefferies downgrades to underperform with a target price of 480p.

Standard Life Aberdeen Aggregate Now Holds 5.1% Stake In Abcam (ALLISS)
12 Mar 2019

Standard Life Aberdeen Aggregate Now Holds 5.1% Stake In Abcam (ALLISS)

LONDON (Alliance News) - Abcam PLC said on Tuesday that an aggregate of Standard Life Aberdeen PLC now holds a 5.1% stake in the company following a t...

LONDON MARKET CLOSE: Downbeat UK Construction Data Helps FTSE Climb
4 Mar 2019

LONDON MARKET CLOSE: Downbeat UK Construction Data Helps FTSE Climb

LONDON (Alliance News) - The FTSE 100 started the week on a positive note, ending safely in the green on Monday as the pound fell following data which...

Abcam falls as outlook overshadows profit growth
4 Mar 2019

Abcam falls as outlook overshadows profit growth

(Sharecast News) - Abcam's shares dropped sharply on Monday after stating its outlook will be impacted by "continued softness" in Japan, though the co...

Abcam Shares Fall On Annual Outlook Despite Profit, Revenue Growth
4 Mar 2019

Abcam Shares Fall On Annual Outlook Despite Profit, Revenue Growth

LONDON (Alliance News) - Shares in Abcam PLC fell sharply Monday on a lacklustre full-year outlook despite the antibody maker and retailer hiking its ...